VeriMomIs anthemis nobilis flower extract safe during pregnancy?
No harmonised CLP reproductive classification for Anthemis nobilis flower extract (ECHA Annex VI has no H360/H361 entry). Regulatory/industry safety assessments and databases (CIR/SCCS absence of adverse flags; EWG lists chamomile as low concern) and lack of published in vivo reproductive toxicity for the extract support no identified reproductive hazard. Topical dermal exposure can result in low but measurable absorption for herbal extracts, so exposure scored as low (adult). Sources: ECHA Annex VI (no harmonised classification), CIR (no reproductive safety restriction), PubChem/ECHA dossiers, EWG.
Pregnancy-safe products containing anthemis nobilis flower extract
Related ingredients
Frequently asked questions
- Is anthemis nobilis flower extract safe during pregnancy?
- No harmonised CLP reproductive classification for Anthemis nobilis flower extract (ECHA Annex VI has no H360/H361 entry). Regulatory/industry safety assessments and databases (CIR/SCCS absence of adverse flags; EWG lists chamomile as low concern) and lack of published in vivo reproductive toxicity for the extract support no identified reproductive hazard. Topical dermal exposure can result in low but measurable absorption for herbal extracts, so exposure scored as low (adult). Sources: ECHA Annex VI (no harmonised classification), CIR (no reproductive safety restriction), PubChem/ECHA dossiers, EWG.
- Is anthemis nobilis flower extract safe while breastfeeding?
- No evidence of maternal reproductive or lactation toxicity or harmonised classification. No specific data showing transfer into breast milk for the extract; topical use implies low but measurable systemic exposure, so low exposure during breastfeeding is plausible. Sources: absence of reproductive/lactation hazard in ECHA/CIR listings and general safety literature (PubChem, EWG).
- Is anthemis nobilis flower extract safe for baby skin?
- No infant-specific reproductive or developmental toxicity data identified for the extract; no harmonised classification. Because infant skin has higher permeability and surface-area-to-weight ratio, exposure rating is increased by one step versus adult (adult e=1 → infant e=2). Clinical concerns for chamomile are primarily topical allergy in sensitive individuals, not developmental toxicity. Sources: ECHA Annex VI (no classification), PubMed/CIR absence of developmental signals, EWG.
- How does VeriMom score anthemis nobilis flower extract?
- VeriMom scores anthemis nobilis flower extract at 93/100 (no known risks) based on EU CosIng status, ECHA hazard classifications, and peer-reviewed PubMed studies. Our scoring pipeline is fully transparent.
- What are pregnancy-safe alternatives to anthemis nobilis flower extract?
- See our curated list of pregnancy-safe alternatives to anthemis nobilis flower extract based on similar function and a no-known-risks safety band.
Check every label in 2 seconds
Get VeriMom free — scan any product and see the pregnancy safety score instantly.
Medical Disclaimer
This information is for educational purposes only and does not constitute medical advice. Safety scores are based on publicly available data and may not reflect all risks. Always consult your healthcare provider before using any product during pregnancy or breastfeeding.